Recommended

Discover how to overcome low affinity or poor TCR yields that are slowing you down in this upcoming webinar – register your details today
WEBINAR | Discover how advances can expand the possibilities for drug discovery, from target validation to preclinical development
Facing roadblocks in obesity drug discovery? Discover how integrated, validated strategies are helping teams accelerate development and reduce risk – register your details now
Unlock the science, strategy and real-world impact behind the next generation of precision therapies – access our new brand report now >>
Safety data is no longer just a regulatory checkbox – it’s a strategic advantage. Find out more in our upcoming webinar, register your details today
Explore how AI is reshaping early drug discovery, from target identification and compound screening to predictive modelling and trial design – register now!
editorial-board

James Adjaye

Chair of Stem Cell Research and Regenerative Medicine, Heinrich Heine University

Prof. Dr. James Adjaye, Chair of Stem Cell Research and Regenerative Medicine and Director of the Institute for Stem Cell Research and Regenerative Medicine, Heinrich Heine UniversityJames Affram Adjaye has a BSc degree in Biochemistry from University College of Cardiff, Wales. He then obtained an MSc in Biochemistry from the University of Sussex, and then PhD (genetic manipulation and molecular biology) from King’s College, London. He is now Director of the Institute for Stem Cell Research and Regenerative Medicine within the Faculty of Medicine at the Heinrich-Heine-Universität, Düsseldorf. He is also Group leader of the Molecular Embryology and Aging Group at the Max Planck Institute for Molecular Genetics in Berlin.

Related organisations

Related people